LENZ Therapeutics's total assets for Q4 2024 were $215.30M, a decrease of -3.89% from the previous quarter. LENZ total liabilities were $11.22M for the fiscal quarter, a 28.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.